TapewireFind a company

person · Reporting owner

Mullan Jill

Disclosed activity across 1 company

Tapewire entity
113386
SEC CIK
0001857039

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
iSpecimen Inc.ISPC · Entity 8372DirectorJanuary 01, 2023May 17, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

iSpecimen Inc.

Report date January 01, 2023 · Filed May 17, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect246,318 Reported balance After 2023-01-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-01-01 · Grant · Acquired 92 · Balance 246,318

F1: Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units ("RSUs") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement.

F2: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units ("RSUs") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement.

F2: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 17, 2023 Filed Jan 19, 2023 21:04 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionOption · Derivative 66,637 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001104659-23-004999 · tm233905-2_4seq1.xml · derivative · entry 2

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 66,637 shares

Expires 2023-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents the stock options that were vested on the date of termination of employment of the Reporting Person and will expire if not exercised by the Reporting Person before January 22, 2023.

F4 · balance_after: Represents remaining granted stock options across all grants.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:04 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionCommon Stock 66,637 $1.00 $66,637.00
Disclosure

SEC source: 0001104659-23-004999 · tm233905-2_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,226

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.

F2 · price: Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.

Read SEC document
January 03, 2023 Filed Jan 19, 2023 21:02 UTC iSpecimen Inc. ISPC · Entity 8372 GrantOption · Derivative 10,000 $1.41 Strike: $1.41 $14,100.00
Disclosure

SEC source: 0001104659-23-004998 · tm233905-1_4seq1.xml · derivative · entry 1

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,637

Underlying: Common Stock · 10,000 shares

Expires 2033-01-03

F1 · derivative.exercise_date: Represents stock options granted to the reporting person on January 3, 2023, pursuant to the Issuer's Amended and Restated 2021 Stock Incentive Plan. The stock options vest with respect to 2,500 shares on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.

F2 · balance_after: Represents remaining granted stock options across all grants.

Read SEC document
January 01, 2023 Filed May 17, 2023 16:34 UTC iSpecimen Inc. ISPC · Entity 8372 GrantCommon Stock 92 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-061740 · tm2315065-5_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,318

F1 · security: Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units ("RSUs") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement.

F1 · shares: Reflects shares of common stock issued to the Reporting Person upon vesting and settlement of restricted stock units ("RSUs") on March 31, 2023, which RSUs were awarded to the Reporting Person as of January 1, 2023, subject to the terms and conditions set forth in the award of such RSUs by the Issuer to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for his service as a director of the Company.

Read SEC document
October 24, 2022 Filed Nov 10, 2022 21:10 UTC iSpecimen Inc. ISPC · Entity 8372 OtherOption · Derivative 564 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-117133 · tm2230264-1_4seq1.xml · derivative · entry 2

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,637

Underlying: Common Stock · 564 shares

Expires 2022-10-24

F3 · derivative.exercise_price: Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date.

F3 · price: Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date.

F3 · derivative.exercise_date: Represents unvested stock options that were forfeited upon the termination of employment of the reporting person with the issuer. Stock options exercisable for an aggregate of 66,637 shares that were vested on the date of termination of employment of the reporting person will expire on January 22, 2023, if not exercised by the reporting person before that date.

Read SEC document
October 24, 2022 Filed Nov 10, 2022 21:10 UTC iSpecimen Inc. ISPC · Entity 8372 OtherCommon Stock 18,229 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-117133 · tm2230264-1_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,589

F1 · security: Pursuant to certain separation agreement, dated October 24, 2022 (the "Separation Agreement"), by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the "RSUs"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited.

F1 · kind: Pursuant to certain separation agreement, dated October 24, 2022 (the "Separation Agreement"), by and between the issuer and the reporting person, (i) an aggregate of 13,021 restricted stock units of the issuer (the "RSUs"), which were previously awarded to the reporting person but not settled, were settled at an accelerated vesting schedule and as a result, 13,021 shares of common stock were issued to the reporting person; and (ii) 18,229 RSUs, which were previously awarded to the reporting person and not settled, were forfeited.

F2 · price: The RSUs were previously awarded as compensation to the reporting person for her former service as an officer of the issuer.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 21:13 UTC iSpecimen Inc. ISPC · Entity 8372 Tax withholdingCommon Stock 3,124 $2.36 $7,372.64
Disclosure

SEC source: 0001104659-22-074370 · tm2219397-3_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,818

F1 · kind: The shares were sold and the proceeds were paid to the Issuer to satisfy tax withholding obligations.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 22:20 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionOption · Derivative 3,099 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001104659-22-026191 · tm227509-1_4seq1.xml · derivative · entry 4

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,201

Underlying: Common Stock · 3,099 shares

Expires 2029-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Represents a portion of the stock options granted to the Reporting Person on February 1, 2019, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on February 1, 2022.

F5 · balance_after: Represents remaining granted stock options across all grants.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 22:20 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionOption · Derivative 19,296 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0001104659-22-026191 · tm227509-1_4seq1.xml · derivative · entry 3

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,300

Underlying: Common Stock · 19,296 shares

Expires 2026-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents a portion of the stock options granted to the Reporting Person on June 30, 2016, pursuant to the Issuer's 2013 Stock Incentive Plan, which were fully vested on June 30, 2019.

F5 · balance_after: Represents remaining granted stock options across all grants.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 22:20 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionCommon Stock 3,099 $1.00 $3,099.00
Disclosure

SEC source: 0001104659-22-026191 · tm227509-1_4seq1.xml · nonDerivative · entry 2

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.

F2 · price: Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 22:20 UTC iSpecimen Inc. ISPC · Entity 8372 Exercise / conversionCommon Stock 19,296 $1.00 $19,296.00
Disclosure

SEC source: 0001104659-22-026191 · tm227509-1_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,843

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Acquisition of shares of common stock by the Reporting Person upon the exercise of stock options.

F2 · price: Represents the $1.00 exercise price per share of the stock options exercised, which was paid by the Reporting Person upon exercise of such stock options.

Read SEC document
July 30, 2021 Filed Feb 14, 2022 20:29 UTC iSpecimen Inc. ISPC · Entity 8372 GrantCommon Stock 52,084 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-22-022565 · tm226491-5_5seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,547

F1 · security: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F1 · shares: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

F2 · price: The RSUs were awarded as compensation to the Reporting Person for her service as an officer of the Company.

F1 · balance_after: Represents shares underlying certain restricted stock units ("RSUs"), each of which is a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in five equal installments, on June 21, 2021, June 21, 2022, June 21, 2023, June 21, 2024 and June 21, 2025, subject to the terms and conditions set forth in the RSU Agreement. 10,416 RSUs were settled for shares of common stock on June 21, 2021, and the Reporting Person was issued 10,416 shares of common stock.

Read SEC document
June 21, 2021 Filed Jun 24, 2021 01:23 UTC iSpecimen Inc. ISPC · Entity 8372 ConversionBridge Note · Derivative 76,897 Not disclosed Strike: $5.60 Not disclosed
Disclosure

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 5

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 76,897 shares

Expires 2021-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F4 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

Read SEC document
June 21, 2021 Filed Jun 24, 2021 01:23 UTC iSpecimen Inc. ISPC · Entity 8372 OtherBridge Note · Derivative 255 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 4

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,897

Underlying: Common Stock · 255 shares

Expires 2021-06-30

F4 · derivative.exercise_price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F5 · shares: Represents accrued interest from June 17, 2021 to June 21, 2021 under the bridge note.

F4 · price: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

F4 · derivative.exercise_date: The bridge note has a maturity date of June 30, 2021 and automatically converted into 76,897 shares of common stock at $5.60 upon the closing of the IPO.

Read SEC document
June 21, 2021 Filed Jun 24, 2021 01:23 UTC iSpecimen Inc. ISPC · Entity 8372 ConversionSeries A Preferred Stock · Derivative 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · derivative · entry 3

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · price: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

F3 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of common stock upon the closing of the Issuer's initial public offering (the "IPO) and has no expiration date.

Read SEC document
June 21, 2021 Filed Jun 24, 2021 01:23 UTC iSpecimen Inc. ISPC · Entity 8372 ConversionCommon Stock 76,897 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · nonDerivative · entry 2

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

F2 · price: Shares were issued to the reporting person upon conversion of an aggregate of $430,625 in principal and accrued interest through June 21, 2021 under a bridge note owed to the reporting person.

Read SEC document
June 21, 2021 Filed Jun 24, 2021 01:23 UTC iSpecimen Inc. ISPC · Entity 8372 ConversionCommon Stock 6,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-084773 · tm2120463-3_4seq1.xml · nonDerivative · entry 1

Mullan Jill · CIK 0001857039 · Director · COO, Secretary, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

F1 · price: Shares were issued to the reporting person upon conversion of the Issuer's Series A Preferred Stock owned through the date of conversion.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.